Clinical Trial Update: Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ritlecitinib for keloids or after keloidectomy is currently recruiting at Mount Sinai.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloids

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Keloid | Phase 2 | Status: RECRUITING